Hemp bark extract improved memory-test performance in scopolamine-treated mice
Hemp bark extract attenuates scopolamine-induced cognitive dysfunction through multi-target cholinesterase, MAO-B, and antioxidant mechanisms.
AI Summary
The study asked whether hemp extracts could protect against cognitive dysfunction through effects on several biological targets. Researchers compared ethanol extracts from hemp root, stem, bark, leaf, and seed, then tested the bark extract in neuronal cells and in mice given scopolamine, a drug used to induce cognitive deficits. In mice, oral hemp bark extract at 100 and 200 mg/kg improved performance in a passive avoidance test and reduced escape latency in a water maze. These are animal findings, not evidence of benefit in people.
In laboratory tests, the bark extract inhibited acetylcholinesterase, butyrylcholinesterase, and MAO-B, and at 0.2 μg/mL reduced reactive oxygen species and restored superoxide dismutase activity in neuronal cells. Chemical analysis identified CBD, cannabidiolic acid, and cannabichromenic acid; enzyme tests found different cannabinoids active against different targets. The findings suggest multiple possible mechanisms, but this abstract-based summary cannot establish that the extract prevents or treats cognitive decline or Alzheimer’s disease in humans. The abstract does not report the number of animals or study duration.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More CBD research papers you might find interesting.
A lab method measures 17 cannabinoids across five hemp product types
CBD showed limited adaptive-functioning differences versus placebo in boys…
NMR profiling finds THC predominates in Moroccan beldia extracts
Explore More Research
Stay informed about the latest cannabis science.